Announcements Trials
Browse Landscape

Status

Completed 3

Sponsor Class

OTHER 120NETWORK 3INDUSTRY 3

Study Type

Observational 3

Sponsor

Cancer Type

Tumor-Agnostic 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Neoplasms 1Mastocytosis, Systemic 1Leukemia, Mast-Cell 1Cancer Genomic Profiling 1

Interventions

Paclitaxel 489Carboplatin 435Gemcitabine 393Docetaxel 385Cisplatin 358pembrolizumab 341Bevacizumab 334Nivolumab 261Pemetrexed 242Capecitabine 221Dexamethasone 212Fluorouracil 211Rituximab 203Trastuzumab 193Cyclophosphamide 190Oxaliplatin 160Erlotinib Hydrochloride 147atezolizumab 145Ipilimumab 145Prednisone 144Cetuximab 142Irinotecan 139Leucovorin 130Doxorubicin 130Sorafenib 120Lenalidomide 117Bortezomib 117Sunitinib 107Everolimus 93130-nm albumin-bound paclitaxel 91

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Interviews as Topic × Clear all
NCT04607889 2022-10-13

A Study to Learn More About What Japanese Patients With Solid Tumors Think About Taking Medicine That is Based on Their Genetic Information

Bayer

Completed
605 enrolled

Cancer Genomic Profiling

NCT03923296 2022-04-06

PERTH 2: Co-design of a Home-based Monitoring Service for Cancer Patients to Optimize Delivery of Systemic Therapy.

Entia Ltd

Completed
62 enrolled
Tumor-Agnostic

Neoplasms

NCT02380222 2017-01-10

Patient-Reported Outcome Questionnaire for Systemic Mastocytosis

Adelphi Values LLC

Completed
5 enrolled
LymphoidMyeloidOther hematologic neoplasm

Leukemia, Mast-Cell, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡